References
- ThassuDDeleersMPathakYNanoparticulate Drug Delivery SystemsNew YorkInforma Healthcare USA, Inc2007
- LiMAl-JamalKTKostarelosKReinekeJPhysiologically based pharmacokinetic modeling of nanoparticlesACS Nano20104116303631720945925
- LaurentSForgeDPortMMagnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applicationsChem Rev200810862064211018543879
- HaoRXingRXuZHouYGaoSSunSSynthesis, functionalization, and biomedical applications of multifunctional magnetic nanoparticlesAdv Mater201022252729274220473985
- HoDSunXSunSMonodisperse Magnetic Nanoparticles for Theranostic ApplicationsAcc Chem Res2011441087588221661754
- LaurentSDutzSHafeliUOMahmoudiMMagnetic fluid hyperthermia: focus on superparamagnetic iron oxide nanoparticlesAdv Colloid Interface Sci20111661–282321601820
- AmstadETextorMReimhultEStabilization and functionalization of iron oxide nanoparticles for biomedical applicationsNanoscale2011372819284321629911
- YooDLeeJHShinTHCheonJTheranostic magnetic nanoparticlesAcc Chem Res2011441086387421823593
- MahmoudiMHosseinkhaniHHosseinkhaniMMagnetic resonance imaging tracking of stem cells in vivo using iron oxide nanoparticles as a tool for the advancement of clinical regenerative medicineChem Rev2011111225328021077606
- YigitMVMooreAMedarovaZMagnetic nanoparticles for cancer diagnosis and therapyPharm Res20122951180118822274558
- WahajuddinAroraSSuperparamagnetic iron oxide nanoparticles: magnetic nanoplatforms as drug carriersInt J of Nanomedicine201273445347122848170
- HilgerIKaiserWAIron oxide-based nanostructures for MRI and magnetic hyperthermiaNanomedicine (Lond)2012791443145922994960
- ReddyLHAriasJLNicolasJCouvreurPMagnetic nanoparticles: design and characterization, toxicity and biocompatibility, pharmaceutical and biomedical applicationsChem Rev2012112115818587823043508
- BulteJWKraitchmanDLIron oxide MR contrast agents for molecular and cellular imagingNMR Biomed200417748449915526347
- RinckPAMagnetic Resonance in Medicine3rd edOxford, UKBlackwell1993
- WangYXSuperparamagnetic iron oxide based MRI contrast agents: Current status of clinical applicationQuant Imaging Med Surg201111354023256052
- NaHBSongICHyeonTInorganic Nanoparticles for MRI Contrast AgentsAdv Mater2009212121332148
- JunYWSeoJWCheonJNanoscaling laws of magnetic nanoparticles and their applicabilities in biomedical sciencesAcc Chem Res200841217918918281944
- PengEWangFXueJMNanostructured magnetic nanocomposites as MRI contrast agentsJ Mater Chem B201531122412276
- HillyerJFAlbrechtRMGastrointestinal persorption and tissue distribution of differently sized colloidal gold nanoparticlesJ Pharm Sci200190121927193611745751
- GeiserMRothen-RutishauserBKappNUltrafine particles cross cellular membranes by nonphagocytic mechanisms in lungs and in cultured cellsEnviron Health Perspect2005113111555156016263511
- Rothen-RutishauserBMSchürchSHaenniBKappNGehrPInteraction of fine particles and nanoparticles with red blood cells visualized with advanced microscopic techniquesEnviron Sci Technol200640144353435916903270
- ApopaPQianYShaoRIron oxide nanoparticles induce human microvascular endothelial cell permeability through reactive oxygen species production and microtubule remodelingPart Fibre Toxicol200961119134195
- KarakotiASDasSThevuthasanSSealSPEGylated Inorganic NanoparticlesAngew Chem Int Ed Engl20115091980199421275011
- LeeJHLeeHBAndradeJDBlood compatibility of polyethylene oxide surfacesProg Polym Sci199520610431079
- StormGBelliotSODaemenTLasicDDSurface modification of nanoparticles to oppose uptake by the mononuclear phagocyte systemAdv Drug Deliv Rev19951713148
- SuhJChoyKLLaiSKPEGylation of nanoparticles improves their cytoplasmic transportInt J Nanomedicine20072473574118203439
- AllenCDos SantosNGallagherRControlling the physical behavior and biological performance of liposome formulations through use of surface grafted poly(ethylene glycol)Biosci Rep200222222525012428902
- MaruyamaKPEG-immunoliposomeBiosci Rep200222225126612428903
- JainNWangYJonesSKHawkettBSWarrGGOptimized steric stabilization of aqueous ferrofluids and magnetic nanoparticlesLangmuir20102664465447219950943
- BryceNSPhamBTTFongNWThe composition and end-group functionality of sterically stabilized nanoparticles enhances the effectiveness of co-administered cytotoxinsBiomater Sci201311212601272
- JainNZhangXHawkettBSWarrGGStable and water-tolerant ionic liquid ferrofluidsACS Appl Mater Interfaces20113366266721338083
- JokerstJVLobovkinaTZareRNGambhirSSNanoparticle PEGy-lation for imaging and therapyNanomedicine (Lond)20116471572821718180
- Allard-VannierECohen-JonathanSGautierJPegylated magnetic nanocarriers for doxorubicin delivery: A quantitative determination of stealthiness in vitro and in vivoEur J Pharm Biopharm201281349850522510695
- HuynhNTRogerELautramNBenoitJPPassiraniCThe rise and rise of stealth nanocarriers for cancer therapy: passive versus active targetingNanomedicine (Lond)2010591415143321128723
- LarsenEKNielsenTWittenbornTAccumulation of magnetic iron oxide nanoparticles coated with variably sized polyethylene glycol in murine tumorsNanoscale2012472352236122395568
- WangZChuiWKHoPCNanoparticulate delivery system targeted to tumor neovasculature for combined anticancer and antiangiogenesis therapyPharm Res201128358559621057857
- KaminskasLMMcLeodVMKellyBDDoxorubicin-conjugated pegylated dendrimers show similar tumoricidal activity but lower systemic toxicity when compared to pegylated liposome and solution formulations in mouse and rat tumor modelsMol Pharm20129342243222233281
- YooHSParkTGFolate-receptor-targeted delivery of doxorubicin nano-aggregates stabilized by doxorubicin–PEG–folate conjugateJ Control Release2004100224725615544872
- HarringtonKJLewanskiCNorthcoteADPhase II study of pegylated liposomal doxorubicin (Caelyx™) as induction chemotherapy for patients with squamous cell cancer of the head and neckEur J Cancer200137162015202211597379
- TassaCShawSYWeisslederRDextran-coated iron oxide nanoparticles: a versatile platform for targeted molecular imaging, molecular diagnostics, and therapyAcc Chem Res2011441084285221661727
- MoadGRizzardoEThangSHRAFT polymerization and some of its applicationsChem Asian J2013881634164423606667
- WellardRMShehanBPCraikDJAdamWRFactors affecting 133Cs chemical shifts in erythrocytes from cesium-fed ratsJ Magn Reson B199410432762798069485
- PowerWPMooibroekSWasylishenRECameronTSCesium-133 single-crystal NMR study of cesium chromateJ Phys Chem199498615521560
- PhilpDJNaumannCKuchelPWRelative intensities of components of quadrupolar-split multiplets in NMR spectra: Rationale for a simple ruleConcepts Magn Reson Part A201240A29099
- KuchelPWChapmanBEBubbWAHansenPEDurrantCJHertzbergMPMagnetic susceptibility: Solutions, emulsions, and cellsConcepts Magn Reson Part A200318A15671
- DurrantCJHertzbergMPKuchelPWMagnetic susceptibility: Further insights into macroscopic and microscopic fields and the sphere of LorentzConcepts Magn Reson Part A200318A17295
- EamegdoolSSWeibleMW2ndPhamBTHawkettBSGrieveSMChan-lingTUltrasmall superparamagnetic iron oxide nanoparticle prelabelling of human neural precursor cellsBiomaterials201435215549556424726535
- PhilipseAPvan BruggenMPPathmamanoharanCMagnetic silica dispersions: preparation and stability of surface-modified silica particles with a magnetic coreLangmuir19941019299
- LeeHLeeEKimDKJangNKJeongYYJonSAntibiofouling polymer-coated superparamagnetic iron oxide nanoparticles as potential magnetic resonance contrast agents for in vivo cancer imagingJ Am Chem Soc2006128227383738916734494
- SaravananPAlamSMathurGNComparative study on the synthesis of γ-Fe2O3 and Fe3O4 nanocrystals using high-temperature solution-phase techniqueJ Mater Sci Lett2003221812831285
- ChantrellRWPopplewellJCharlesSMeasurements of particle size distribution parameters in ferrofluidsMagnetics, IEEE Transactions1978145975977
- LartigueLInnocentiCKalaivaniTWater-dispersible sugar-coated iron oxide nanoparticles. An evaluation of their relaxometric and magnetic hyperthermia propertiesJ Am Chem Soc201113327104591047221604803
- ShehanBPWellardRMAdamWRCraikDJThe use of dietary loading of 133Cs as a potassium substitute in NMR studies of tissuesMagn Reson Med19933055735828259057
- ShehanBPWellardRMCraikDJAdamWR133Cs relaxation times in rat tissuesJ Magn Reson B199510721791857599952
- WellardRMAdamWRFunctional hepatocyte cation compartmentation demonstrated with 133Cs NMRMagn Reson Med200248581081812417995